Inhaled corticosteroids plus salmeterol or montelukast: Effects on resource utilization and costs
- 1 March 2002
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 109 (3) , 433-439
- https://doi.org/10.1067/mai.2002.121953
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-upRespiratory Medicine, 2001
- Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid TherapyChest, 2001
- One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthmaJournal of Allergy and Clinical Immunology, 2001
- Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukastJournal of Allergy and Clinical Immunology, 2000
- Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)BMJ, 2000
- Comparison of inhaled salmeterol and oral zafirlukast in patients with asthmaJournal of Allergy and Clinical Immunology, 1999
- A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthmaJournal of Allergy and Clinical Immunology, 1999
- Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1999
- Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthmaJournal of Allergy and Clinical Immunology, 1997
- Smearing Estimate: A Nonparametric Retransformation MethodJournal of the American Statistical Association, 1983